
Opthea Limited OPT
Annual report 2022
added 09-29-2022
Opthea Limited ROE Ratio 2011-2026 | OPT
Annual ROE Ratio Opthea Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -193.46 | -33.52 | -24.96 | - | -44.28 | -11.36 | -43.45 | -25.41 | -41.91 | -35.35 | -25.58 | -47.04 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -11.36 | -193.46 | -47.85 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Exelixis
EXEL
|
36.21 | $ 48.43 | 9.03 % | $ 13.2 B | ||
|
Fortress Biotech
FBIO
|
13.66 | $ 2.56 | 3.96 % | $ 71.4 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Galapagos NV
GLPG
|
-11.44 | $ 28.78 | 1.36 % | $ 2.69 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
Genmab A/S
GMAB
|
24.88 | $ 27.93 | 1.41 % | $ 17.2 B | ||
|
Genprex
GNPX
|
-203.83 | $ 0.9 | 2.02 % | $ 839 K | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Grifols, S.A.
GRFS
|
9.2 | $ 8.41 | 1.69 % | $ 6.83 B | ||
|
Athira Pharma
ATHA
|
-380.03 | - | - | $ 269 M | ||
|
InflaRx N.V.
IFRX
|
-43.64 | $ 2.47 | 25.39 % | $ 152 M | ||
|
Ionis Pharmaceuticals
IONS
|
-46.9 | $ 76.96 | 2.27 % | $ 12.3 B | ||
|
Kamada Ltd.
KMDA
|
9.59 | $ 8.3 | 1.1 % | $ 260 M | ||
|
BioNTech SE
BNTX
|
1.11 | $ 95.07 | -0.45 % | $ 27.2 B | ||
|
Kymera Therapeutics
KYMR
|
-19.71 | $ 86.14 | 4.15 % | $ 7.28 B | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
-0.49 | $ 229.83 | -1.06 % | $ 4.2 B | ||
|
INmune Bio
INMB
|
-195.26 | $ 1.52 | -1.3 % | $ 37.6 M | ||
|
Liquidia Corporation
LQDA
|
-154.03 | $ 41.84 | 4.26 % | $ 3.6 B | ||
|
Mirum Pharmaceuticals
MIRM
|
-7.42 | $ 107.42 | 1.52 % | $ 5.39 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
30.9 | $ 22.32 | -0.13 % | $ 3.7 B | ||
|
MannKind Corporation
MNKD
|
-11.49 | $ 3.68 | 28.5 % | $ 1.12 B | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
Nanobiotix S.A.
NBTX
|
-47.67 | $ 42.28 | 21.6 % | $ 286 B | ||
|
Esperion Therapeutics
ESPR
|
7.51 | $ 3.13 | 0.55 % | $ 651 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 3.47 | -8.44 % | $ 5.71 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 23.86 | 1.88 % | $ 3.04 B | ||
|
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | ||
|
Puma Biotechnology
PBYI
|
23.87 | $ 7.5 | 2.04 % | $ 375 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B |